Latest news
Parkinson’s therapy reduces disease biomarkers in 12-week trial - Parkinson's News TodayParkinson's News Today · Fri, 07 Aug 2026 14:12:40 GMTABLi reports biomarker findings from risvodetinib study for Parkinson’s - Clinical Trials ArenaClinical Trials Arena · Wed, 05 Aug 2026 10:22:34 GMTABLi Therapeutics Announces Outcomes from its - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:05:00 GMT